BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang YJ, Ho CL, Cheng KH, Kuo WI, Lee WC, Lan KL, Chang CH. Biodistribution, pharmacokinetics and radioimmunotherapy of 188Re-cetuximab in NCI-H292 human lung tumor-bearing nude mice. Invest New Drugs 2019;37:961-72. [PMID: 30612308 DOI: 10.1007/s10637-018-00718-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhu T, Hsu JC, Guo J, Chen W, Cai W, Wang K. Radionuclide-based theranostics - a promising strategy for lung cancer. Eur J Nucl Med Mol Imaging 2023. [PMID: 36929181 DOI: 10.1007/s00259-023-06174-8] [Reference Citation Analysis]
2 Zhang L, Zhao S, Jiang H, Zhang R, Zhang M, Pan W, Sun Z, Wang D, Li J. Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer. EJNMMI Res 2022;12:70. [DOI: 10.1186/s13550-022-00939-2] [Reference Citation Analysis]
3 Rousseau J, Lau J, Bénard F. Radiolabeled Antibodies for Cancer Radioimmunotherapy. Nuclear Medicine and Immunology 2022. [DOI: 10.1007/978-3-030-81261-4_14] [Reference Citation Analysis]
4 Lo WL, Lo SW, Chen SJ, Chen MW, Huang YR, Chen LC, Chang CH, Li MH. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice. Int J Mol Sci 2021;22:5459. [PMID: 34064291 DOI: 10.3390/ijms22115459] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 White JM, Escorcia FE, Viola NT. Perspectives on metals-based radioimmunotherapy (RIT): moving forward. Theranostics 2021;11:6293-314. [PMID: 33995659 DOI: 10.7150/thno.57177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
6 Yin J, Xin B, Hui X, Chai N, Yao L, Hu H, Xu B, Ma W, Zhang M, Wang J, Nie Y, Zhou G, Wang G, Chen L, Lu H, Wu K. 188Re-labeled GX1 dimer as a novel dual-functional probe targeting TGM2 for imaging and antiangiogenic therapy of gastric cancer. Eur J Pharm Biopharm 2020;154:144-52. [PMID: 32682942 DOI: 10.1016/j.ejpb.2020.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]